113 related articles for article (PubMed ID: 6886282)
1. A controlled long-term study with ergoloid mesylates (Hydergine) in healthy, elderly volunteers: results after three years.
Spiegel R; Huber F; Köberle S
J Am Geriatr Soc; 1983 Sep; 31(9):549-55. PubMed ID: 6886282
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term ergoloid mesylates ('Hydergine') administration in healthy pensioners: 5-year results.
Huber F; Köberle S; Prestele H; Spiegel R
Curr Med Res Opin; 1986; 10(4):256-79. PubMed ID: 3780290
[TBL] [Abstract][Full Text] [Related]
3. A long-term study with co-dergocrine mesylate (Hydergine) in healthy pensioners. Results after 3 years.
Köberle S; Spiegel R
Gerontology; 1984; 30 Suppl 1():3-52. PubMed ID: 6489764
[TBL] [Abstract][Full Text] [Related]
4. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
van Loveren-Huyben CM; Engelaar HF; Hermans MB; van der Bom JA; Leering C; Munnichs JM
J Am Geriatr Soc; 1984 Aug; 32(8):584-8. PubMed ID: 6379022
[TBL] [Abstract][Full Text] [Related]
5. Ergoloid mesylates ('Hydergine') in the treatment of mental deterioration in the elderly: a 6-month double-blind, placebo-controlled trial.
Rouy JM; Douillon AM; Compan B; Wolmark Y
Curr Med Res Opin; 1989; 11(6):380-9. PubMed ID: 2651014
[TBL] [Abstract][Full Text] [Related]
6. Ergoloid mesylates and ECT.
Sachs GS; Gelenberg AJ; Bellinghausen B; Wojcik J; Falk WE; Farhadi AM; Jenike M
J Clin Psychiatry; 1989 Mar; 50(3):87-90. PubMed ID: 2647711
[TBL] [Abstract][Full Text] [Related]
7. Lack of efficacy of hydergine in patients with Alzheimer's disease.
Thompson TL; Filley CM; Mitchell WD; Culig KM; LoVerde M; Byyny RL
N Engl J Med; 1990 Aug; 323(7):445-8. PubMed ID: 2082953
[TBL] [Abstract][Full Text] [Related]
8. Posttranslational changes in band 3 in adult and aging brain following treatment with ergoloid mesylates, comparison to changes observed in Alzheimer's disease.
Cover CC; Poulin JE; Gustafson MR; Wyant T; Gamble DN; Kay MM
Life Sci; 1996; 58(8):655-64. PubMed ID: 8594315
[TBL] [Abstract][Full Text] [Related]
9. Ergoloid mesylates for senile dementias: unanswered questions.
Hollister LE; Yesavage J
Ann Intern Med; 1984 Jun; 100(6):894-8. PubMed ID: 6372566
[TBL] [Abstract][Full Text] [Related]
10. [Effect of Hydergine on arterial pressure, cardiac rate and the electrocardiogram in normal and pathological cases in childhood].
PACI A; GIORGI PL; BERTOCCHI G; BRUNAZZI S
Riv Clin Pediatr; 1962 Jun; 69():377-85. PubMed ID: 13940963
[No Abstract] [Full Text] [Related]
11. The ergoloid mesylate dihydroergotoxine: radioimmunoassay measurements on plasma and blood-pressure-lowering activity.
Woodcock BG; Habedank WD; Loh W; Rietbrock N
J Cardiovasc Pharmacol; 1984; 6(3):543-5. PubMed ID: 6202984
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with lecithin and ergoloid mesylates for Alzheimer's disease.
Jenike MA; Albert MS; Heller H; LoCastro S; Gunther J
J Clin Psychiatry; 1986 May; 47(5):249-51. PubMed ID: 3700343
[TBL] [Abstract][Full Text] [Related]
13. Mental decline in the elderly: pharmacotherapy (ergot alkaloids versus papaverine).
Rosen HJ
J Am Geriatr Soc; 1975 Apr; 23(4):169-74. PubMed ID: 803997
[TBL] [Abstract][Full Text] [Related]
14. [Letter: Double blind study of hydergine in aged patients].
Paux G; Boismare F; Delaunay P
Nouv Presse Med; 1975 Oct; 4(35):2529. PubMed ID: 812060
[No Abstract] [Full Text] [Related]
15. Neuropharmacological studies on hydergine.
Depoortere H; Loew DM; Vigouret JM
Triangle; 1975; 14(2):73-9. PubMed ID: 812222
[No Abstract] [Full Text] [Related]
16. Hydrogenated ergot alkaloids (hydergine) in the treatment of geriatric postural dizziness.
ORMA EJ
Ann Med Intern Fenn; 1956; 45(1):39-44. PubMed ID: 13355071
[No Abstract] [Full Text] [Related]
17. [Study on the function of the sinus node and supra- and sub-Hisian A-V conduction in subjects with excitocondution changes after a dihydroergocristine test].
Molinis G; Disertori M; Inama G; Furlanello F
Minerva Cardioangiol; 1976 Jan; 24(1):1-7. PubMed ID: 815847
[No Abstract] [Full Text] [Related]
18. [Effects of the administration of the drug association: hydergine-thioridazine (HM 51), in the treatment of coronary angina].
Martelli A; Melilla GN
G Clin Med; 1968 Mar; 49(3):310-43. PubMed ID: 4985903
[No Abstract] [Full Text] [Related]
19. Co-dergocrine plasma concentrations and blood pressure changes in hypertensive patients during therapy with slow-release co-dergocrine mesylate.
Woodcock BG; Herrmann W; Habedank WD
Int J Clin Pharmacol Ther Toxicol; 1992 Feb; 30(2):63-5. PubMed ID: 1551748
[TBL] [Abstract][Full Text] [Related]
20. The effect of hydergine on the enzymes involved in cAMP turonver in the brain.
Enz A; Iwangoff P; Markstein R; Wagner H
Triangle; 1975; 14(2):90-2. PubMed ID: 173058
[No Abstract] [Full Text] [Related]
[Next] [New Search]
